Sudarshan Churna Indications: Useful in all kinds of chronic fevers & anorexia developed due to chronic fevers. Especially useful in malarial fevers and remittent type of fevers.
Ingredients:
Each 5gms. Contains: Harad (Terminaliachebula), Bahera (TerminaliaBellerica), Amla (Emblicaofficinalis), Haldi (Curcuma longa), Daruhaldi (Berberis aristata), Laghu kantkari (Solanum frutescens), Brihat kantkari (Solanum indicum), Kachur (Curcuma zeodaria), Piplamool (Piper longum root), Giloy (Tinospora cordifolia), Dhamasa (Fagonia cretica), Kutki (Picrorhiza kurroa), Mustak (Cyperus rotundus), Parpat (Fumaria vallantii), Vidang (Embelia ribes), Netra bala (Sida rhombifolia), Neem chhal (Melia azardirachta), Pushkermool (Inula racemosa), Mulethi (Glycyrrhiza glabra), Kutaj chhal (Halorrhena antidysentrica), Ajwain (Trachyspermum ammi), Bharangi (Clerodendron serratum), Inder yav(Citrullus colocynthis), Shigrubeej (Moringa Pterygosperma), Saphutika (Alum), Vacha (Acoruscalamus), Dalchini (Cinnamumzeylanicum), Padmakh (Prunuscerasoides), Khas (Vetiveria zizanioidis), Shvet Chandan (Santalum album), Ativisa (Aconitum hetrophylum), Bala (Sida cordifolia), Shalparni (Desmodium gangeticum), Trayamana (Gentiana Kurroa), Tagar (Valeriana wallichii), Chitrakmool (Plumbago zeylanicum), Devdaru (Cedrus deodara), Chavya (Piper retrofractum), Patol patra (Trichosanthes dioica), Jivak (Microstylis muscifera), Rishbhak (Microstylis wallichii), Lavang (Syzygium aromaticus), Vanshlochan (Bambusa arundinacea), Kamalpushp (Nelumbo nucifera), Kakoli (Lilium polyphyllum), Tej patra (Cinnamum inners), Javitari (Myristica fragrans), Talis patra (Abies webbiana), Shalparni (Uraria picta) Karanj beej (Pongamia Pinnata), Pippali (Piper longum), Kalmegh (Andrographis paniculata), Murva (Marsdenia tenacissima)-1.26% of each of the above ingredients, Chirayta (Swertia Chirayita) 33.39%.
Dosage of Sudarshan Churna
3 to 6 gms. twice in a day with water or as directed by the physician.
Presentation:
Available in 100 gms Pack.
Reviews
There are no reviews yet.